14 January, 2024 by Anshul (neobio)
When it comes to conquering cancer, one size does not fit all. That’s where targeted cancer therapy steps in. Instead of following the traditional “one drug fits all” approach, targeted therapies are like the sharpshooters of cancer treatment, precisely identifying and attacking specific types of cancer cells.
Unlike classic chemotherapy treatments that can often harm healthy cells along with cancerous ones, targeted therapy homes in on the distinct differences between normal cells and cancer cells. These therapies are designed to intervene with specific proteins and genes that aid cancerous tumors in their growth and spread.
To make the concept crystal clear, here’s a distilled understanding of what targeted cancer therapy is:
Targeted therapy is primarily recommended for patients whose tumor cells carry specific genetic changes or proteins that these drugs are designed to target. This is determined through genomic tests, which identify the genetic makeup of the cancer cells. If these tests reveal the presence of the specific genetic targets, targeted therapy could be the optimal treatment choice. However, even if the cancer cells carry the targeted genetic changes or proteins, it’s important to note that the tumor may not always respond to the drug. This is a complex field, and the right drug for a patient depends on multiple factors.
The effectiveness of targeted therapy varies widely, depending on the type of cancer and the specific genetic changes present in the tumor. In some cases, targeted therapies have been shown to significantly slow the growth of cancer and reduce the size of the tumor. However, the response to treatment may not always be long-lasting. Over time, cancer cells can adapt and become resistant to the therapy, leading to the drug becoming less effective.
Targeted therapy is often used in combination with other cancer treatments such as surgery, radiation therapy, chemotherapy, hormone therapy, or immunotherapy. The combination of treatments can be more effective than using any one treatment alone. For instance, targeted therapy can be used to shrink a tumor before surgery, making it easier to remove. Or it can be used after surgery to kill any remaining cancer cells, reducing the risk of the cancer returning.
The duration of targeted therapy can vary depending on the type of cancer, the specific drug being used, and how well the cancer responds to treatment. Some people may receive targeted therapy for a few months, while others may continue treatment for several years. Regular check-ups and tests will help your doctor assess the effectiveness of the treatment and decide on the duration of therapy.
Just like any form of cancer treatment, targeted cancer therapy also has its challenges and side effects.
One of the significant challenges of targeted therapy is resistance. Over time, cancer cells can adapt and become resistant to the drugs used in targeted therapy. This resistance can occur when the target molecule itself changes, preventing the drug from interacting with it. Additionally, cancer cells could develop new growth pathways that do not depend on the target molecule.
The most common side effects of targeted therapies include diarrhea and liver problems. Patients may also experience problems with blood clotting and wound healing, high blood pressure, fatigue, mouth sores, nail changes, the loss of hair color, and skin problems such as rash or dry skin. In rare cases, a hole might form through the wall of the esophagus, stomach, or intestine.
Most side effects of targeted therapy go away after treatment ends. There are also medicines available to prevent or treat these side effects once they occur.
To determine whether targeted therapy is working, patients undergo regular examinations and medical tests, such as blood tests, x-rays, and scans. Through these evaluations, doctors can monitor the progress of the treatment and make necessary adjustments.
Targeted cancer therapy represents a major shift in how we approach cancer treatment, offering precision, improved outcomes, and often fewer side effects compared to traditional chemotherapy. By focusing on the unique genetic makeup of cancer cells, these therapies can deliver more effective and personalized care. However, they are not without challenges, such as drug resistance and individual variability in response. Ongoing monitoring, genomic testing, and thoughtful integration with other treatment modalities are key to maximizing the benefits of targeted therapy and advancing the future of cancer care.